| 标题 |
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lung Cancer 作者:Fangdi Sun; Mandeep K. Banwait; Surbhi Singhal; Amanda Herrmann; Zofia Piotrowska; et al 出版日期:2025-09-07 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)